Back to Search
Start Over
Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic.
- Source :
-
European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 04; Vol. 10 (6), pp. 479-480. - Publication Year :
- 2024
- Subjects :
- Humans
Dyslipidemias drug therapy
Dyslipidemias diagnosis
Dyslipidemias blood
Dyslipidemias genetics
Pharmacogenomic Testing
Treatment Outcome
Cardiovascular Diseases genetics
Cardiovascular Diseases diagnosis
Cardiovascular Diseases drug therapy
Cardiovascular Diseases prevention & control
Lipids blood
Pharmacogenomic Variants
Predictive Value of Tests
Genetic Testing
Pharmacogenetics
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Clinical Decision-Making
Precision Medicine
Hypolipidemic Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2055-6845
- Volume :
- 10
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- European heart journal. Cardiovascular pharmacotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 39364572
- Full Text :
- https://doi.org/10.1093/ehjcvp/pvae061